Global HIV, Hepatitis and STIs Programmes
The Department of Global HIV, Hepatitis and Sexually Transmitted Infections Programmes leads the development and implementation of the global health sector strategy on the elimination of the diseases as public health threats.
News
All →Events
Call for experts
Publications
All →The Global Action Plan on HIV drug resistance 2017–2021 provided a comprehensive framework for global and country action and outlined a package of...
14 April 2023
New recommendation on hepatitis C virus testing and treatment for people at ongoing risk of infection
In 2022, WHO published the Consolidated guidelines on HIV, viral hepatitis and STI prevention, diagnosis, treatment and care for key populations....
14 April 2023
Recommended package of interventions for HIV, viral hepatitis and STI prevention, diagnosis, treatment...
In 2022, WHO published the Consolidated guidelines on HIV, viral hepatitis and STI prevention, diagnosis, treatment and care for key populations. These...
3 April 2023
Integrating the prevention and control of noncommunicable diseases in HIV/AIDS, tuberculosis, and sexual...
The global community has made great progress in reducing major health burdens in recent decades, including advances in infectious disease control and treatment,...
People with advanced HIV disease are at very high risk of opportunistic infections and deaths. Despite good progress worldwide towards goals of HIV testing,...
15 March 2023
Sentinel surveys of acquired HIV resistance to dolutegravir among people receiving dolutegravir-containing...
WHO’s sentinel surveys of acquired HIV resistance to dolutegravir among people receiving dolutegravir-containing antiretroviral therapy is ...
22 February 2023
HIV self-testing at workplaces: approaches to implementation and sustainable financing
Countries are making progress toward the global goal of 95% of people living with HIV knowing their status by 2025. However, considerable gaps remain in...
19 December 2022
Using recency assays for HIV surveillance: 2022 technical guidance
Recency assays use one or more biomarkers to identify whether HIV infection in a person is recent (usually within a year or less) or longstanding. Recency...
